Literature DB >> 1414586

Cytokine activation of killer cells in mycobacterial immunity.

D K Blanchard1.   

Abstract

Mycobacterium avium-intracellulare (MAI) is an ubiquitous soil contaminant that rarely causes disseminated disease in adults, regardless of immunological status. In AIDS patients, however, this microorganism invades virtually every tissue and organ, and most conventional chemotherapeutic agents are usually ineffective against MAI. We report here that monocytes, in which MAI has established an intracellular parasitic stage, appear to be under the control of natural killer (NK) cells. Autologous large granular lymphocytes (LGL), purified from human peripheral blood mononuclear cells (PBMC), were capable of efficiently lysing MAI-infected monocytes in a 5 hr 51Cr-release assay. More importantly, interleukin 2 (IL-2) was able to activate the LGL to a high degree of lysis of infected monocytes. Additionally, 3 to 4 days of incubation of LGL with MAI resulted in the induction of killer cells capable of killing bacterially-infected monocytes, as well as tumor cells. Northern blot analysis of RNA from MAI-stimulated LGL revealed specific messages for both IL-2 receptor proteins (p55 and p70). Thus, MAI can directly activate killer cells, which may therefore play a role in containment of MAI infection by lysis of parasitized monocytes before the bacteria can multiply and spread to other sites.

Entities:  

Mesh:

Substances:

Year:  1992        PMID: 1414586     DOI: 10.1007/978-1-4615-3434-1_12

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  2 in total

1.  Intralymphatic interleukin-2 in combination with zidovudine for the therapy of patients with AIDS.

Authors:  T Harrer; J Schwab; W G Struff; M Schmitt; J H Ficker; W Rödl; H Parsch; J R Kalden; M Gramatzki
Journal:  Infection       Date:  1998 Nov-Dec       Impact factor: 3.553

2.  Modulation of mucosal immunity against Campylobacter jejuni by orally administered cytokines.

Authors:  S Baqar; N D Pacheco; F M Rollwagen
Journal:  Antimicrob Agents Chemother       Date:  1993-12       Impact factor: 5.191

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.